{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:56:41Z","timestamp":1772071001724,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.4158\/ep161607.or","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T14:46:50Z","timestamp":1481726810000},"page":"299-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA"],"prefix":"10.1016","volume":"23","author":[{"given":"Salem A.","family":"Beshyah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aly B.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim H.","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"Benbarka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Abbas","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiam","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Chadli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP161607.OR_bb0010","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40618-016-0505-x","article-title":"Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any)","volume":"39","author":"Bartalena","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP161607.OR_bb0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn","year":"2011","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/thy.2011.2106.ed3","article-title":"The American Thyroid Association\/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective","volume":"21","author":"Kahaly","year":"2011","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/thy.2011.2106.ed1","article-title":"The American Thyroid Association and American Association of Clinical Endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines: viewpoints from Japan and Korea","volume":"21","author":"Yamashita","year":"2011","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0030","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161607.OR_bb0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0040","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves disease: a global overview","volume":"9","author":"Bartalena","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP161607.OR_bb0050","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves' disease","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161607.OR_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves' disease","volume":"84","author":"Bartalena","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161607.OR_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000444482","article-title":"A 2015 Italian survey of clinical practice patterns in the management of Graves' disease: Comparison with European and North American surveys","volume":"5","author":"AME (Associazione Medici Endocrinologi) and AACE (American Association of Clinical Endocrinologists) Italian Chapter","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.4158\/EP161607.OR_bb0065","unstructured":"World Bank. Available at: http:\/\/www.worldbank.org\/en\/region\/mena\/overview. Accessed November 1, 2016."},{"key":"10.4158\/EP161607.OR_bb0070","first-page":"3","article-title":"The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey","volume":"285","author":"Glinoer","year":"1987","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"key":"10.4158\/EP161607.OR_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1507\/endocrj1954.36.299","article-title":"The Japan Thyroid Association. The management of hyperthyroidism due to Graves' disease in Japan in 1988","volume":"36","author":"Nagayama","year":"1989","journal-title":"Endocrinol Jpn"},{"key":"10.4158\/EP161607.OR_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.1997.7.225","article-title":"Case selection and restrictions recommended to patients with hyperthyroidism in South America","volume":"7","author":"Romaldini","year":"1997","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/thy.1997.7.217","article-title":"International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China","volume":"7","author":"Tominaga","year":"1997","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States","volume":"1","author":"Wartofsky","year":"1991","journal-title":"Thyroid"},{"key":"10.4158\/EP161607.OR_bb0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1445-5994.2000.tb00856.x","article-title":"Management of Graves' disease in Australia","volume":"30","author":"Walsh","year":"2000","journal-title":"Aust NZ J Med"},{"key":"10.4158\/EP161607.OR_bb0100","first-page":"163","article-title":"The management of Graves' disease by Indian thyroidologists","volume":"6","author":"Mithal","year":"1993","journal-title":"Natl Med J India"},{"key":"10.4158\/EP161607.OR_bb0105","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.healthpol.2016.06.005","article-title":"Medicine and democracy: The importance of institutional quality in the relationship between health expenditure and health outcomes in the MENA region","volume":"120","author":"Bousmah","year":"2016","journal-title":"Health Policy"},{"key":"10.4158\/EP161607.OR_bb0110","first-page":"363","article-title":"The first clinical congress of the Gulf Chapter of the American Association of Clinical Endocrinologists","volume":"5","author":"Khalil","year":"2013","journal-title":"Ibnosina J Med BS"},{"key":"10.4158\/EP161607.OR_bb0115","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2012.05.012","article-title":"Imaging of thyrotoxicosis","volume":"125","author":"Sipos","year":"2012","journal-title":"Am J Med"},{"key":"10.4158\/EP161607.OR_bb0120","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161607.OR_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4158\/EP11120.ED","article-title":"The American Thyroid Association and American Association of Clinical Endocrinologists' guidelines for hyperthyroidism and other causes of thyrotoxicosis: an appraisal","volume":"17","author":"Daniels","year":"2011","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161607.OR_bb0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.1.02201","article-title":"A questionnaire survey on the management of Graves' orbitopathy in Europe","volume":"155","author":"European Group of Graves' Orbitopathy","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161607.OR_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"European Group on Graves' Orbitopathy (EUGOGO): Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161607.OR_bb0140","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline","volume":"97","author":"De Groot","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:03:37Z","timestamp":1761516217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20358316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1530891X20358316"],"URL":"https:\/\/doi.org\/10.4158\/ep161607.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161607.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}